Amgen Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (100)

Latest Posts

About This Stock More About This Stock
The Best Growth Stocks For Dividend Investors
Article By: SureDividend
Sunday, February 4, 2018 11:00 AM EDT
Here is a spotlight on my favorite high growth dividend growth investing names for investors who don’t need income in the present, but instead, hope to lay down the building blocks of a strong passive income stream far into the future.
In this article: NKE, AAPL, NVDA, BA, DIS, MA, V, AMGN, CMCSA, SBUX Also: JNJ, MCD
What’s Next After Profit Taking Hits Biotech And Drug Stocks?
Article By: Rod Raynovich
Thursday, February 1, 2018 6:38 PM EDT
The biotech sector hit a wall after breaking through to new highs last week. Is disruption coming to healthcare?
In this article: AMGN, IBB, XBI Also: XLV, REGN, RHHBY, ABBV, SGEN
Week In Review: Hua Medicine To Raise $200 Million Through Fundings And IPO For Oral Diabetes Drug
Article By: ChinaBio® Today
Saturday, January 13, 2018 6:23 PM EDT
Hua Medicine of Shanghai expects to spend $200 million over the next three years on its novel oral diabetes 2 treatment, dorzagliatin. The company will raise additional capital for the effort and then IPO, possibly in Hong Kong or the US.
In this article: VRACY, BSTG, VAR, AZN, BMY, AMGN, BGNE
3 ETFs To Watch On Biotech Earnings
Article By: Zacks Investment Research
Sunday, October 29, 2017 5:13 PM EDT
The earnings season is off to a flying start with equity markets. However, the performance has been a mixed bag for biotech companies with some beating market expectations, while a few failed to do so.
In this article: ALXN, AMGN, BIIB, BIB, IBB, BBH, GILD
Amgen May Pull Back Before The Next Surge
Article By: Bob Lang
Wednesday, October 18, 2017 9:38 AM EDT
Will Amgen provide another ideal entry point? The chart says yes.
In this article: AMGN


Latest Tweets for $AMGN

No tweets yet!


July 2017 Stock Considerations
Dick Kaplan 7/3/2017 3:14:44 AM

I read that #Repatha sales for this quarter are down significantly so be careful with $AMGN.

1 to 1 of 1 comments